News Nov 03, 2023 CSL joins Basel biotech cluster The research and development department of the globally active Australian biotech company CSL has moved into a new office in the Switzerland Inno...
News Oct 16, 2023 Adiposs completes the phase I clinical trial of its flagship product ImageBAT Geneva-based biotech Adiposs casts a ray of hope onto the horizons of cancer treatment and patient care with the successful conclusion of the Pha...
News Nov 06, 2023 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
Success stories May 25, 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News Jan 20, 2021 Swiss PharmaCan successfully tests anti-COVID drug Swiss PharmaCan and Australia-based MGC Pharma have successfully concluded phase II clinical testing for their COVID-19 therapeutic candidate, Ar...
News Oct 13, 2021 Thermo Fisher Scientific opens biologics manufacturing site in Lengnau, Switzerland Thermo Fisher’s new Swiss site – consisting of a 1.5 million square-foot biologics facility with up to 12,500 liters of bioreactor capacity – wil...
News Mar 27, 2019 Western Switzerland welcomed 92 new foreign companies in 2018 The Greater Geneva Bern area (GGBa), together with the economic development offices of its six member cantons, contributed to the establishment o...
News Sep 25, 2018 Basel Areal Business & Innovation welcomes BeiGene to Basel BeiGene, Ltd., a global commercial-stage biopharmaceutical company, has established a regional headquarters in Basel. BaselArea.swiss assisted Be...
News Jan 30, 2018 Joint venture to research cancer therapies in Basel The Basel-based company TargImmune Therapeutics AG and the Australian Race Oncology Limited are entering into a joint venture to develop new canc...